Medical Procedure News

RSS

Endologix implants Ventana stent graft for endovascular repair at Auckland City Hospital

Endologix, Inc. developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand.

3 Nov 2010

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix Suture Anchor system (SpeedFix™). SpeedFix, a push-in anchor made of PEEK (polyether-etherketone) polymer, is designed for the repair of certain tears of the labrum in a shoulder.

3 Nov 2010

Atrium completes enrollment in iCAST Atrium Registry Ultrasound Study

Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.

2 Nov 2010

African Americans more likely to have uterine cancer recurrence

African Americans are more likely to have a recurrence of uterine cancer despite undergoing a total hysterectomy or a hysterectomy followed by radiation therapy, according to researchers at Henry Ford Hospital in Detroit.

2 Nov 2010

$Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients$

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

2 Nov 2010

Study confirms acupuncture as a viable tool for weight loss

Could a few pinpricks make someone thinner. Evidence weighs heavily in favor of that proposition, according to the results of a new study to be presented at the Pacific Symposium in San Diego this week. The groundbreaking study, "The Effects of Acupuncture on Weight-Loss in Over-Weight and Obese Adults Over 24 Years Old," reports that 95 percent of its subjects lost weight in a six-week period after receiving regular acupuncture treatments. Of those subjects, another 50 percent continued to lose weight after treatments stopped.

2 Nov 2010

Fat filling for facial rejuvenation

Aging will affect all of us. Fillers are most commonly used to fill the deep lines around the mouth. Dr. Hardaway, a prominent Farmington Hills, Michigan plastic surgeon states that many patients now prefer to have their own fat injected to fill those unwanted wrinkles.

2 Nov 2010

FDA approves Medtronic Talent Thoracic Stent Graft with Captivia Delivery System

Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug Administration (FDA) of the Talent Thoracic Stent Graft with Captivia® Delivery System, which features a tip capture mechanism for controlled deployment and precise placement of the implantable medical device.

2 Nov 2010

IMRT safe and effective treatment for paranasal tumors: Study

Treating paranasal sinus cancer with three-dimensional radiation that conforms to the shape of the tumor-a technique that minimizes side effects such as severe dry mouth and vision problems-is safe and effective, research at Fox Chase Cancer Center shows. Aruna Turaka, M.D., radiation oncologist at Fox Chase, will present the results on November 2nd at the annual meeting of the American Society for Radiation Oncology.

1 Nov 2010

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

BSD Medical Corporation, the company that pioneered heat therapy applications, today reported that the Company has received CE Mark approval for the commercial sale of The MicroThermX Microwave Ablation System (MTX-180) in Europe. CE marking approval allows BSD to market the MTX-180 in the 30 countries that comprise the European Union (EU) and the European Free Trade Association (EFTA).

1 Nov 2010

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.

1 Nov 2010

Gore announces new Early TIPS for Ascites Study

W.L. Gore & Associates (Gore) today announced a new prospective, randomized, multi-center study at the Annual Meeting of the American Association for the Study of Liver Diseases. The hypothesis of the study is that early intervention with the GORE® VIATORR® TIPS Endoprosthesis improves transplant-free survival when compared to large volume paracentesis in patients with cirrhosis and difficult to treat ascites.

1 Nov 2010

Varian's Acuros XB dose calculation algorithm for radiotherapy receives FDA 510(k) clearance

Varian Medical Systems has received FDA 510(k) clearance for the Acuros® XB advanced dose calculation algorithm which can complete a RapidArc® treatment plan two to three times faster than conventional planning algorithms. Varian has incorporated the Acuros algorithm for external beam radiotherapy treatment planning into its market-leading Eclipse™ treatment planning system on exhibit at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego October 31 - November 4.

1 Nov 2010

American Psychological Association blocking therapists from learning effective treatments for PTSD

In the wake of enormous controversy about its role in the participation of psychologists in the use of torture to extract information from prisoners at Guantanamo Bay and in other parts of the world, an interview just carried by Truthout reveals a new round of criticism that has been directed toward the American Psychological Association (APA).

1 Nov 2010

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.

1 Nov 2010

UCSD announces agreement with PHP to develop UC San Diego Proton Therapy and Research Center

Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.

1 Nov 2010

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

1 Nov 2010

Study determines long-term clinical outcome of patients posttransplant after anitviral therapy

Researchers from the University of Bari, Italy, concluded that treating patients after transplantation with antiviral therapy creates a sustained viral response (SVR) and protects them from liver-related deaths. The purpose of this study was to determine the long-term clinical outcomes of patients posttransplant who underwent antiviral therapy for recurrent hepatitis C virus (HCV) infection of the liver graft.

1 Nov 2010

Brigham and Women's, and UI Hospitals and Clinics begin certification for SynCardia artificial heart implantation

SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.

30 Oct 2010

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Total hip arthroplasty (THA) is one of the most successful surgeries of the past several decades. This procedure has relieved pain and restored movement to hundreds of thousands of people. The decision to have hip replacement surgery should be only made after discussion between the patient and his or her orthopaedic surgeon.

30 Oct 2010

Medical Procedure News

Endologix implants Ventana stent graft for endovascular repair at Auckland City Hospital

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

Atrium completes enrollment in iCAST Atrium Registry Ultrasound Study

African Americans more likely to have uterine cancer recurrence

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

Study confirms acupuncture as a viable tool for weight loss

Fat filling for facial rejuvenation

FDA approves Medtronic Talent Thoracic Stent Graft with Captivia Delivery System

IMRT safe and effective treatment for paranasal tumors: Study

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

Gore announces new Early TIPS for Ascites Study

Varian's Acuros XB dose calculation algorithm for radiotherapy receives FDA 510(k) clearance

American Psychological Association blocking therapists from learning effective treatments for PTSD

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

UCSD announces agreement with PHP to develop UC San Diego Proton Therapy and Research Center

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Study determines long-term clinical outcome of patients posttransplant after anitviral therapy

Brigham and Women's, and UI Hospitals and Clinics begin certification for SynCardia artificial heart implantation

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News